Salute e Benessere

DBV Technologies to Participate in the Guggenheim 2nd Annual Healthcare…

DBV Technologies to Participate in the Guggenheim 2 ndAnnual Healthcare Innovation Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company, today announced Daniel Tassé, Chief Executive Officer, will participate in a fireside chat at the Guggenheim 2 ndAnnual Healthcare Innovation Conference on Tuesday, November 11, at 2:00 p.m. ET in Boston, Massachusetts.A live webcast of the...
Nasdaq GlobeNewswire
04/11/2025

Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for…

REYKJAVIK, ICELAND (November 4, 2025)– Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results for the first nine months of the year ended September 30, 2025, after U.S. markets close on Wednesday, November 12, 2025. Alvotech will also conduct a conference call to present the financial results on Thursday November 13, 2025, at 8:00 am EST (13:00...
Nasdaq GlobeNewswire
04/11/2025

INTREPID Alliance Launches Antiviral Toolbox to Support Global Research…

Small-molecule antivirals are indispensable tools for rapid, scalable, and equitable responses to epidemic and pandemic threats.1 INTREPID's latest review of the global antiviral R&D landscape reveals that beyond Coronaviridae, only 27 antiviral compounds are in clinical development to tackle 12 viral families and their multiple diseases of greatest pandemic concern. Furthermore, there are no clinical development efforts underway for 4 viral families of pandemic potential (Paramyxoviridae…
PR Newswire
04/11/2025

Healthcare Analytics Market Size to grow USD 532.75 Billion by 2035, at 25.75%…

Healthcare analytics encompassing descriptive, predictive, and prescriptive tools—has evolved into a core pillar of executive decision-making, allowing leaders to convert massive healthcare data sets into actionable intelligence. Through AI, cloud computing, and real-time analytics, the industry is achieving unprecedented progress in personalized care, cost efficiency, and data transparency. Healthcare analytics encompassing descriptive, predictive, and prescriptive tools—has evolved into a...
PR Newswire
04/11/2025

DMS GROUP RECEIVES FDA CLEARANCE FOR ITS !M1 MOBILE RADIOLOGY SYSTEM AS PART OF…

A new strategic milestone in DMS Group's expansion in North America ahead of RSNA 2025 November 4, 2025 – 5:45 pm – Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 – ALDMS), a specialist in high-performance medical imaging systems for digital radiology and bone densitometry, announces that its !M1 mobile radiology system has…
Actusnews Wire
04/11/2025

Point-of-Care Molecular Diagnostics Market Surges to USD 15.2 Billion by 2033…

Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=819568 Download PDF Brochure:https://www.verifiedmarketreports.com/download-sample/?rid=819568 Browse in-depth TOC on Point-of-Care Molecular Diagnostics Market 202 - Pages 126 – Tables 37 – Figures Scope of The Point-of-Care Molecular Diagnostics Market Report Global Point-of-Care Molecular Diagnostics Market Overview Point-of-Care Molecular Diagnostics Market: Trends and...
PR Newswire
04/11/2025

Drill Surgical Power Tool Market Amid Rising Surgical Demand and Advancing…

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=285778 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=285778 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Drill Surgical Power Tool Market Overview 1. Rising Demand for Orthopedic and Trauma Surgeries The Drill Surgical Power Tool Market is strongly supported by the growing global incidence of orthopedic disorders, trauma...
PR Newswire
04/11/2025

Bariatric Beds Market to Reach $583.8 million, Globally, by 2034 at 5.3% CAGR…

Request Sample of the Report on Bariatric Beds Market Forecast 2034 - https://www.alliedmarketresearch.com/request-sample/A62724 Request Sample of the Report on Bariatric Beds Market Forecast 2034 -https://www.alliedmarketresearch.com/request-sample/A62724 Market Introduction Bariatric beds comprise specialized hospital and homecare beds designed to accommodate patients with obesity or morbid obesity, typically supporting weights above standard hospital bed limits. These beds...
PR Newswire
04/11/2025

Blood Collection Devices Market worth $13.02 billion by 2030 with 7.4% CAGR |…

Browse in-depth TOC on "Blood Collection Devices Market" Browse in-depth TOC on "Blood Collection Devices Market" 374 - Tables50 - Figures321 - Pages By product,the global blood collection devices market is segmented into blood collection tubes, needles & syringes, blood collection systems/monitors, blood bags, and lancets. In 2024, the blood collection tubes segment accounted for the largest share of the blood collection devices market. The strong position of this...
PR Newswire
04/11/2025

Global AI-Powered Pathology Market Valued at USD 184 Million in 2023, Set to…

The global AI-Powered Pathology Market is projected to grow significantly in the coming years. It was valued at USD 184 Million in 2023 and is forecast to reach USD 382 Million by 2030, representing a robust compound annual growth rate (CAGR) of 11.7% during 2024–2030. The global AI-Powered Pathology Market is projected to grow significantly in the coming years. It was valued atUSD 184 Millionin 2023 and is forecast to reachUSD 382 Millionby 2030, representing a robust compound annual...
PR Newswire
04/11/2025

MOBILion Systems to Present Transformative Advances in Proteomics Sensitivity…

As proteomics research increasingly emphasizes PTMs and proteoforms as critical indicators in drug development and clinical diagnostics, technologies that enhance detection depth and confidence are reshaping how scientists interrogate biological complexity. MOBILion's PAMAF technology enables near-100% ion utilization and delivers industry-leading spectral generation rates exceeding 500Hz. This performance advancement can only be achieved via MOBILion's high-speed HRIM separation and reduces the…
PR Newswire
04/11/2025

Novo Nordisk submits updated proposal to acquire Metsera, Inc.

Bagsværd, Denmark, 4 November 2025– On 30 October 2025, Novo Nordisk announced the submission of an unsolicited proposal to acquire Metsera, Inc. (Metsera) 1.Today, Novo Nordisk confirms that it has submitted an updated, unsolicited proposal to acquire Metsera. The updated proposal has been declared superior by Metsera’s board of directors.The acquisition of Metsera, including its early and development-stage incretin and non-incretin analogue peptide programmes, would provide Novo...
Nasdaq GlobeNewswire
04/11/2025

ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT OCTOBER 2025

Accumulated revenue for January – October 2025 increased by 55% to SEK 2,629.7 (1,693.2) million. Accumulated revenue for January –October 2025increased by 55% to SEK 2,629.7 (1,693.2) million. Revenues were distributed as follows: Countries in regions: -The Nordics:Denmark, Faroe Island,Finland,Iceland,Norway,Sweden - Central Europe :Austria,Germany,Switzerland - East Europe :Czech Republic,Slovakia,Hungary,Poland,Romania -South...
PR Newswire
04/11/2025

Trading by management and close relations of management

In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B. The released shares relate to the 2022 legacy Chr. Hansen matching shares program and the legacy Chr. Hansen 2023 restricted stock units (RSU) program...
Nasdaq GlobeNewswire
04/11/2025

Renowned Pharma and Biotech Development Leader, Dr. Andreas Wallnöfer, is named…

(“ Optigo ”), an ophthalmology company pioneering next-gen treatments for retinal diseases, today announced that Dr. Andreas Wallnöfer is joining its Board of Directors as the company advances its lead program to IND-enabling studies.“Andreas is exactly the strategic leader and industry veteran we were looking for,” said Dr. Henning Afflerbach, Chair of the Board of Optigo. “His singular blend of operational experience — from bench to boardroom — and his track record of guiding programs...
Nasdaq GlobeNewswire
04/11/2025

Metabolon Powers Largest-Ever Veteran Metabolomics Study with Global Discovery…

Launched by the U.S. Department of Veterans Affairs in 2011, the Million Veteran Program is a landmark initiative exploring how genetics, lifestyle, military service, and environmental exposures affect health. With over one million enrolled veterans as of November 2023, MVP collects biospecimens, health surveys, and electronic medical records to power a secure, diverse, and expansive multiomics database. Veteran-focused research provides a window into the health effects of extreme stress…
PR Newswire
04/11/2025

Coloplast Finance B.V. - Annual Report, 2024/25

Hereby please find the Annual Report 2024/25 for the group of Coloplast A/S. Attachment 11_2025_Annual_Report_2024-25
Nasdaq GlobeNewswire
04/11/2025

Boehringer Ingelheim and CDR-Life Expand Collaboration Efforts with Global…

New deal builds on the success of a longstanding partnership in retinal health and the potential of CDR-Life’s unique antibody fragment-based platform Agreement provides potential for up to approx. USD 570 million in total payments including approx. USD 48 million in upfront and near-term payments, plus tiered royalties Ingelheim, Germany and Zurich , Switzerland – November4 , 2025– Boehringer Ingelheim and CDR-Life, Inc. today announced a new global licensing...
Nasdaq GlobeNewswire
04/11/2025

AmacaThera Signs Exclusive Global Licensing Agreement with Pacira BioSciences…

Under the terms of the agreement, AmacaThera will receive US$5 million upfront and up to US$225 million in future development- and sales-based milestone payments and a tiered royalty on future net sales. The companies will collaborate on clinical development, with AmacaThera leading select clinical studies. Pacira will fund clinical development of AMT-143 through commercial launch. Pacira and AmacaThera expect to initiate a Phase 2 trial in 2026, after which Pacira will assume full…
PR Newswire
04/11/2025

Zelluna ASA: Notice of extraordinary general meeting on 25 November 2025

The Company's board of directors (the "Board") hereby calls for an extraordinary general meeting on 25 November 2025 at 09:00 CET (the "EGM") to resolve upon proposals by the Board to issue the new shares in tranche 2 of the private placement and to authorize the Board to issue new shares in a potential subsequent repair offering, as further described in the attached EGM notice.The EGM will be held electronically. For participation, please log in…
Nasdaq GlobeNewswire
04/11/2025

AC Immune Reports Third Quarter 2025 Financial Results and Provides a Corporate…

AC Immune Reports Third Quarter 2025 Financial Results and Provides a Corporate UpdateSharpened investment focus on high-value assets, including three Phase 2 active immunotherapy programs and small molecule programs targeting NLRP3, Tau and a-synCash resources of CHF 108.5 million as of September 30, 2025, provide funding to the end of Q3 2027 excluding any income from potential milestonesPeer-reviewed papers covering groundbreaking results including clinical data on ACI-35...
Nasdaq GlobeNewswire
04/11/2025

Sky Labs Attracts Investment With Omron Subsidiary 'OMRON VENTURES'

In addition, it has also signed a Memorandum of Understanding (MoU) with OMRON Healthcare Co., Ltd.(Head Office: Muko, Kyoto, President & CEO: Ayumu Okada) a global blood pressure monitoring market leader, regarding strengthening its strategic partnership. In addition, it has also signed a Memorandum of Understanding (MoU) with OMRON Healthcare Co., Ltd.(Head Office: Muko,Kyoto, President & CEO:Ayumu Okada ) a global blood pressure monitoring market leader, regarding strengthening its...
PR Newswire
04/11/2025

Elastomeric Infusion Pumps Market worth $1.49 billion by 2030 - Exclusive Report…

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=10422815 Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=10422815 Elastomeric infusion pumps are advanced, non-electronic medical devices that enable controlled, continuous drug delivery in home care, hospice, and ambulatory settings. These devices are commonly used in the management of oncology, pain management, and palliative care, providing a safe, accurate, and portable...
PR Newswire
04/11/2025

Next-Generation Multiple Myeloma Therapies Market to Reach USD 37.07 Billion by…

Download PDF Brochure: https://www.datamintelligence.com/download-sample/next-generation-multiple-myeloma-therapies-market Download PDF Brochure:https://www.datamintelligence.com/download-sample/next-generation-multiple-myeloma-therapies-market Browse in-depth TOC on "Next-Generation Multiple Myeloma Therapies Market" 73 – Tables 67 – Figures 199 – Pages Beyond therapeutics, diagnostics are experiencing a paradigm shift. A multicenter trial usingwhole-body MRI (MY-RADS)...
PR Newswire
04/11/2025
Altri  Comunicati